Expression and activation of the steroidogenic enzyme CYP11A1 is associated with IL-13 production in T cells from peanut allergic children.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 03 01 2020
accepted: 07 05 2020
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 22 8 2020
Statut: epublish

Résumé

Activation of the steroidogenic enzyme CYP11A1 was shown to be necessary for the development of peanut-induced intestinal anaphylaxis and IL-13 production in allergic mice. We determined if levels of CYP11A1 in peripheral blood T cells from peanut-allergic (PA) children compared to non-allergic controls were increased and if levels correlated to IL-13 production and oral challenge outcomes to peanut. CYP11A1 mRNA and protein levels were significantly increased in activated CD4+ T cells from PA patients. In parallel, IL-13 production was significantly increased; IFNγ levels were not different between groups. There were significant correlations between expression levels of CYP11A1 mRNA and levels of IL13 mRNA and protein, levels of serum IgE anti-Ara h 2 and to outcomes of peanut challenge. The importance of CYP11A1 on cytokine production was tested using a CYP11A1 CRISPR/Cas9 KO plasmid or an inhibitor of enzymatic CYP11A1 activity. Inhibition of CYP11A1 activation in patient cells treated with the inhibitor, aminoglutethimide, or CD4+ T cell line transfected with the CYP11A1 KO plasmid resulted in reduced IL-13 production. These data suggest that the CYP11A1-CD4+Tcell-IL-13 axis in activated CD4+ T cells from PA children is associated with development of PA reactions. CYP11A1 may represent a novel target for therapeutic intervention in PA children.

Identifiants

pubmed: 32497050
doi: 10.1371/journal.pone.0233563
pii: PONE-D-20-00239
pmc: PMC7272076
doi:

Substances chimiques

IL13 protein, human 0
Interleukin-13 0
RNA, Messenger 0
Aminoglutethimide 0O54ZQ14I9
Cholesterol Side-Chain Cleavage Enzyme EC 1.14.15.6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0233563

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

J Allergy Clin Immunol. 2001 Jan;107(1):191-3
pubmed: 11150011
J Allergy Clin Immunol. 2018 Mar;141(3):991-1001
pubmed: 29030101
Exp Biol Med (Maywood). 2009 Aug;234(8):880-907
pubmed: 19491374
Allergy. 2013 Feb;68(2):220-8
pubmed: 23253182
J Clin Invest. 2003 Nov;112(9):1437-43
pubmed: 14597769
J Allergy Clin Immunol. 2014 Feb;133(2):291-307; quiz 308
pubmed: 24388012
J Clin Invest. 2003 Apr;111(7):1065-72
pubmed: 12671056
J Allergy Clin Immunol. 1997 Oct;100(4):444-51
pubmed: 9338535
Clin Exp Allergy. 2001 Jul;31(7):1031-5
pubmed: 11467993
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):53-6
pubmed: 10887305
Lancet. 2001 Dec 1;358(9296):1871-2
pubmed: 11741628
J Immunol Methods. 1995 Dec 15;188(1):117-28
pubmed: 8551029
Int Arch Allergy Immunol. 2014;165(3):179-94
pubmed: 25531161
J Allergy Clin Immunol. 2012 Dec;130(6):1260-74
pubmed: 23195525
J Allergy Clin Immunol. 2010 Aug;126(2):306-16, 316.e1-12
pubmed: 20624645
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):80-4
pubmed: 21195129
Exp Mol Med. 2018 Apr 16;50(4):20
pubmed: 29657326
FASEB J. 1999 May;13(8):893-901
pubmed: 10224232
Endocrinology. 2003 Oct;144(10):4285-8
pubmed: 12959982
Mol Endocrinol. 2008 Apr;22(4):915-23
pubmed: 18174359
Clin Exp Allergy. 2005 Mar;35(3):268-73
pubmed: 15784102
Endocrinology. 2001 Aug;142(8):3519-29
pubmed: 11459798
J Allergy Clin Immunol. 2010 Jul;126(1):92-7.e5
pubmed: 20538332
J Allergy Clin Immunol. 2013 Nov;132(5):1174-1183.e8
pubmed: 23870673
Cell Rep. 2014 May 22;7(4):1130-42
pubmed: 24813893
J Exp Med. 2004 Dec 20;200(12):1635-46
pubmed: 15596520
Nat Commun. 2016 Jan 11;7:10213
pubmed: 26750596
Nat Rev Immunol. 2016 Dec;16(12):751-765
pubmed: 27795547
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8152-7
pubmed: 23630275
N Engl J Med. 2015 Feb 26;372(9):803-13
pubmed: 25705822
Ann Allergy Asthma Immunol. 2008 Mar;100(3 Suppl 3):S1-148
pubmed: 18431959
Mol Endocrinol. 2007 Apr;21(4):948-62
pubmed: 17213386
J Immunol. 2007 Dec 1;179(11):7406-14
pubmed: 18025184

Auteurs

Meiqin Wang (M)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Matthew J Strand (MJ)

Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO, United States of America.

Bruce J Lanser (BJ)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Carah Santos (C)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Kreso Bendelja (K)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Jennifer Fish (J)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Elizabeth A Esterl (EA)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Shigeru Ashino (S)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Jordan K Abbott (JK)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Vijaya Knight (V)

Advanced Diagnostic Laboratories, National Jewish Health, Denver, CO, United States of America.

Erwin W Gelfand (EW)

Department of Pediatrics, Division of Cell Biology, National Jewish Health, Denver, CO, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH